In this regard, we tested the hypothesis that pre-operative GLP-1 levels vary among groups of patients with different outcomes of T2D after RYGB, and the GLP-1 response differs during a 2-h oral glucose tolerance test (OGTT) between control subjects and obese patients with and without T2D. The gene discussed is GCG; the disease is type 2 diabetes mellitus.